MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia–Taiwan 2026

Precision Microneedle Manufacturer Empowering Next-Generation Skincare Through Advanced Transdermal Delivery Systems

As the global skincare industry continues to shift from ingredient-focused formulations to delivery-focused innovation, MicroDoctor Cosmetics will showcase its latest dissolving microneedle technologies and advanced transdermal delivery systems at BIO Asia–Taiwan 2026.

Powered by MicroDoctor Biomedical, MicroDoctor Cosmetics is a Beauty Technology company specializing in precision-engineered dissolving microneedle platforms that bridge biomedical engineering with next-generation skincare innovation. Backed by more than three decades of precision manufacturing expertise from Darwin Precisions Corporation, the company combines optical-grade micro-molding technology with scalable manufacturing capabilities to help global beauty brands develop differentiated, science-driven skincare products.

Unlike conventional topical skincare, dissolving microneedles are designed to overcome the skin barrier by delivering active ingredients through precisely engineered microstructures. Using a proprietary micro-molding manufacturing process, MicroDoctor Cosmetics precisely controls microneedle geometry, sharpness, density, and tip consistency, ensuring reliable skin penetration, controlled ingredient delivery, and consistent product performance across large-scale production.

At BIO Asia–Taiwan 2026, the company will present its comprehensive microneedle platform, including:

Dissolving Microneedle Patch

Two-Step Microneedle Eye Patch

Microneedle Roller

Hydrogel Eye Patch

Advanced Microneedle Transdermal Delivery System

Beyond finished products, MicroDoctor Cosmetics provides an integrated development platform for beauty brands worldwide, including Ready-to-Launch skincare solutions, custom formula development, private label manufacturing, and scalable commercial production.

Manufactured in Taiwan under internationally recognized quality standards, including ISO 22716 Cosmetics GMP and Quality Management System (QMS), the company's manufacturing platform supports partners from concept development and formulation to commercial-scale production with reliable quality and manufacturing consistency.

"Skincare innovation is no longer defined only by better ingredients—it is increasingly defined by better delivery," said Michael Tsai, Chairman of MicroDoctor Biomedical.

"At MicroDoctor Cosmetics, we combine precision engineering with dissolving microneedle technology to create reliable transdermal delivery platforms that enable beauty brands to develop high-performance skincare with greater consistency, scalability, and market differentiation. We believe microneedle technology will become one of the defining innovations in next-generation skincare."

Building on the biomedical expertise of MicroDoctor Biomedical, the company continues to advance microneedle science through continuous innovation in micro-molding, precision manufacturing, and transdermal delivery technologies. By integrating engineering, biomedical research, and scalable manufacturing, MicroDoctor Cosmetics aims to become a trusted global partner for beauty brands seeking innovative microneedle skincare solutions.

Visitors are invited to meet the MicroDoctor team at BIO Asia–Taiwan 2026 to explore the future of dissolving microneedle technology, advanced transdermal delivery systems, and next-generation skincare innovation.